143 related articles for article (PubMed ID: 30218772)
21. Analysis of the base excision repair genes MTH1, OGG1 and MUTYH in patients with squamous oral carcinomas.
Görgens H; Müller A; Krüger S; Kuhlisch E; König IR; Ziegler A; Schackert HK; Eckelt U
Oral Oncol; 2007 Sep; 43(8):791-5. PubMed ID: 17207658
[TBL] [Abstract][Full Text] [Related]
22. Association of genetic polymorphism of BCL-2 (rs2279115) with susceptibility to HCV-related hepatocellular carcinoma.
Ahmed HS; Wahab EA; Elhady HA; Elgerby MM
Immunol Res; 2020 Aug; 68(4):189-197. PubMed ID: 32623689
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C virus induces oxidative stress, DNA damage and modulates the DNA repair enzyme NEIL1.
Pal S; Polyak SJ; Bano N; Qiu WC; Carithers RL; Shuhart M; Gretch DR; Das A
J Gastroenterol Hepatol; 2010 Mar; 25(3):627-34. PubMed ID: 20074151
[TBL] [Abstract][Full Text] [Related]
24. Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV.
Mosaad YM; Metwally SS; Farag RE; Lotfy ZF; AbdelTwab HE
Immunol Invest; 2019 Apr; 48(3):321-332. PubMed ID: 30321082
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms in MICA, but not in DEPDC5, HCP5 or PNPLA3, are associated with chronic hepatitis C-related hepatocellular carcinoma.
Hai H; Tamori A; Thuy LTT; Yoshida K; Hagihara A; Kawamura E; Uchida-Kobayashi S; Morikawa H; Enomoto M; Murakami Y; Kawada N
Sci Rep; 2017 Sep; 7(1):11912. PubMed ID: 28928439
[TBL] [Abstract][Full Text] [Related]
26. IL12 Gene Polymorphism in Association with Hepatocellular Carcinoma in HCV-infected Egyptian Patients.
Elsayed HM; Nabiel Y; Sheta T
Immunol Invest; 2017 Feb; 46(2):123-133. PubMed ID: 27819525
[TBL] [Abstract][Full Text] [Related]
27. Association of base excision repair gene polymorphisms with ESRD risk in a Chinese population.
Cai Z; Chen H; Tao J; Guo W; Liu X; Zheng B; Sun W; Wang Y
Oxid Med Cell Longev; 2012; 2012():928421. PubMed ID: 22720119
[TBL] [Abstract][Full Text] [Related]
28. The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C.
Nischalke HD; Coenen M; Berger C; Aldenhoff K; Müller T; Berg T; Krämer B; Körner C; Odenthal M; Schulze F; Grünhage F; Nattermann J; Sauerbruch T; Spengler U
Int J Cancer; 2012 Mar; 130(6):1470-5. PubMed ID: 21500195
[TBL] [Abstract][Full Text] [Related]
29. Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma.
Lange CM; Bibert S; Dufour JF; Cellerai C; Cerny A; Heim MH; Kaiser L; Malinverni R; Müllhaupt B; Negro F; Semela D; Moradpour D; Kutalik Z; Bochud PY;
J Hepatol; 2013 Sep; 59(3):504-9. PubMed ID: 23665287
[TBL] [Abstract][Full Text] [Related]
30. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
Zekri AR; Bahnassy AA; Abdel-Wahab SA; Khafagy MM; Loutfy SA; Radwan H; Shaarawy SM
J Gastroenterol Hepatol; 2009 Mar; 24(3):416-28. PubMed ID: 19054267
[TBL] [Abstract][Full Text] [Related]
31. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
Motawi TK; Shaker OG; Ismail MF; Sayed NH
Gene; 2013 Sep; 527(2):516-20. PubMed ID: 23845776
[TBL] [Abstract][Full Text] [Related]
32. RECK Gene Promoter rs10814325 Polymorphism in Egyptian Patients with Hepatocellular Carcinoma on Top of Chronic Hepatitis C Viral Infection.
Fakhry AB; Ahmed AI; AbdelAlim MA; Ramadan DI
Asian Pac J Cancer Prev; 2016; 17(5):2383-8. PubMed ID: 27268601
[TBL] [Abstract][Full Text] [Related]
33. [Interaction between the single-nucleotide polymorphism of DNA repair gene hOGG1 and HBV infection and its susceptibility to hepatocellular carcinoma].
Ji L; Zeng X; Li L; Qiu X; Chen S; Yu H
Wei Sheng Yan Jiu; 2011 Nov; 40(6):705-8. PubMed ID: 22279661
[TBL] [Abstract][Full Text] [Related]
34. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.
Fabris C; Falleti E; Cussigh A; Bitetto D; Fontanini E; Bignulin S; Cmet S; Fornasiere E; Fumolo E; Fangazio S; Cerutti A; Minisini R; Pirisi M; Toniutto P
J Hepatol; 2011 Apr; 54(4):716-22. PubMed ID: 21146242
[TBL] [Abstract][Full Text] [Related]
35. Association of IL28B gene polymorphism with development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C virus infection.
Joshita S; Umemura T; Katsuyama Y; Ichikawa Y; Kimura T; Morita S; Kamijo A; Komatsu M; Ichijo T; Matsumoto A; Yoshizawa K; Kamijo N; Ota M; Tanaka E
Hum Immunol; 2012 Mar; 73(3):298-300. PubMed ID: 22245236
[TBL] [Abstract][Full Text] [Related]
36. Genetic Investigation of Polymorphic OGG1 and MUTYH Genes Towards Increased Susceptibility in Lung Adenocarcinoma and its Impact on Overall Survival of Lung Cancer Patients Treated with Platinum Based Chemotherapy.
Singh A; Singh N; Behera D; Sharma S
Pathol Oncol Res; 2019 Oct; 25(4):1327-1340. PubMed ID: 29209987
[TBL] [Abstract][Full Text] [Related]
37. Glutathione-S-transferase and microsomal epoxide hydrolase polymorphism and viral-related hepatocellular carcinoma risk in India.
Kiran M; Chawla YK; Kaur J
DNA Cell Biol; 2008 Dec; 27(12):687-94. PubMed ID: 18816171
[TBL] [Abstract][Full Text] [Related]
38. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic marker.
Jiao X; Luo Y; Yang B; Jing L; Li Y; Liu C; Jing X; Wang F; Wang Y; Du Z; Gao Y
Infect Genet Evol; 2017 Apr; 49():66-72. PubMed ID: 28082187
[TBL] [Abstract][Full Text] [Related]
39. Genetic variants in IL-6 and IL-10 genes and susceptibility to hepatocellular carcinoma in HCV infected patients.
Sghaier I; Mouelhi L; Rabia NA; Alsaleh BR; Ghazoueni E; Almawi WY; Loueslati BY
Cytokine; 2017 Jan; 89():62-67. PubMed ID: 28340949
[TBL] [Abstract][Full Text] [Related]
40. MDM2 promoter SNP309 is associated with the risk of hepatocellular carcinoma in patients with chronic hepatitis C.
Dharel N; Kato N; Muroyama R; Moriyama M; Shao RX; Kawabe T; Omata M
Clin Cancer Res; 2006 Aug; 12(16):4867-71. PubMed ID: 16914573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
